
The AI that delivers pharma R&D decisions in days, not months
iollo was founded by Daniel Gomari (PhD Computational Biology, Stanford) and Prof. Mike Snyder (Stanford Genetics, 900+ publications) after watching pharma companies spend millions and months making R&D decisions that could be computed in days. We built Quinn to fix that. Quinn is an AI scientist that runs autonomous scientific workflows and delivers high-stakes R&D decisions to Fortune 500 pharma companies.
Own the infrastructure Quinn runs on in production.
Quinn runs autonomous scientific workflows inside enterprise pharma environments. Each customer gets an isolated deployment with dedicated storage and compute. Runs are long-lived, concurrent, and compute-intensive. The engineering challenge: deploy securely into customer-controlled cloud infrastructure, keep data fully isolated across tenants, and keep production reliable for customers where infrastructure failures have real business consequences.
AWS (compute, storage, identity, networking), Python, TypeScript, workflow orchestration, serverless compute. SOC 2/ISO 27001 compliant environments.
You'd be the person Quinn depends on to run. Enterprise pharma already trusts Quinn with their highest-stakes R&D decisions. You make sure the infrastructure never gives them a reason to stop. If you want to own that, let's talk.
iollo has developed Quinn, our AI scientist to analyze multimodal biomedical data to discover new biology in hours, work that typically takes teams of scientists years. Quinn translates these discoveries into accelerated development of novel therapeutic strategies and interventions for extending healthspan.